Astrazeneca Rises on Profit Beat; Paramount Pauses WBD Deal | Stock Movers
On this episode of Stock Movers: - Forte Bioscience (FBRX) is soaring as Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its portfolio of immunology medicines. - Astrazeneca (AZN) shares rose after it reported higher-than-expected profit, buoyed by blockbuster cancer medicines, with earnings per share rising 21% to $2.63 last quarter. - Paramount Skydance (PSKY) shares are reacting to news that it paused its blockbuster deal for Warner Bros.
_1447241_640x360_2508622403601-640x360.webp&w=3840&q=75)
_1447190_640x360_2508618307612-640x360.webp&w=3840&q=75)
_1447169_640x360_2508609603994-640x360.webp&w=3840&q=75)
_1447162_640x360_2508610115951-640x360.webp&w=3840&q=75)
_1447140_640x360_2508602947742-640x360.webp&w=3840&q=75)
_1447047_640x360_2508592707883-640x360.webp&w=3840&q=75)
_1447012_640x360_2508593731719-640x360.webp&w=3840&q=75)




